Safaricom names Debra Mallowah as Chief of Business Development Officer

GlaxoSmithKline Consumer Healthcare EA General Manager Debra Mallowah appointed Safaricom’s Chief of Business Development Officer.

She will be in charge of strategy, innovation and regional expansion a position that was headed by Joseph Ogutu.

Ogutu has been appointed Safaricom’s Chief Business Development Officer but in an interim capacity.

“As a member of the Executive Committee and reporting directly to me, Debra will be responsible for preparing Safaricom for the future, harnessing new business opportunities and leading innovation,” said Bob Collymore Safaricom’s chief executive.
Collymore said Mallowah will take over responsibility for Alpha, Safaricom’s innovation unit and will lead geographical expansion opportunities including Mergers and Acquisitions activities.
“As the Executive responsible for developing the company’s strategic direction she will also lead the new Knowledge Management team including Research as well as Insights & Big Data.”
The appointment of Mallowah is part of management changes announced by the company that also saw the creation of the position of Chief Customer Officer. 
“The new organisational structure has seen the positions of chief officers created, with the appointees now handling redistributed portfolios as well as new roles designed to aid the company in its efforts to embrace a data-driven, insights-led, customer-obsessed approach to business,” said Collymore.